RCKT - יחס חוב להיוון בספרים Rocket Pharma

The Rocket Pharmaceuticals (RCKT) sector operates in an autonomous cycle independent of global economic fluctuations, rendering it a resilient asset. Rocket Pharmaceuticals focuses on treating blood and heart pathologies, receiving payments from insurance funds and government agencies, with the indicator standing at 0.07. This daily price action, visualized for analytical convenience, confirms the business status as a closed bioplatform with unique patent protection.

This ratio determines the degree of business dependence on borrowed funds by comparing total liabilities to the amount of equity on the balance sheet. By analyzing the financial leverage chart based on book capitalization, an investor assesses the stability of the financing structure of Rocket Pharmaceuticals (RCKT), which is critical when establishing patent barriers and developing costly gene therapy methods for orphan diseases.